Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Acta Physiologica (Oxford, England)|January 3, 2022
Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra-coronary aortic bandingPing Yu Xiong, Mehras Motamed, Kuang-Hueih Chen, et al.Journal of Child Neurology|May 22, 2025
Experiences and Hope in Caregivers of Children With Aicardi Goutières SyndromeFrancesco Gavazzi, Ashley Martin, Anjana Sevagamoorthy, et al.Headache|February 8, 2023
Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experimentTodd J Schwedt, Ashley Martin, Steven Kymes, et al.Plos Pathogens|January 19, 2019
Zika virus infection at mid-gestation results in fetal cerebral cortical injury and fetal death in the olive baboonSunam Gurung, Nicole Reuter, Alisha Preno, et al.Metabolomics : Official Journal of the Metabolomic Society|September 17, 2013
Stearoyl-CoA desaturase enzyme 1 inhibition reduces glucose utilization for de novo fatty acid synthesis and cell proliferation in 3T3-L1 adipocytesJennifer K Yee, Paulin N Wahjudi, Juan Vega, et al.Pediatric Obesity|September 14, 2025
Exposure to Metal Mixtures and Childhood Adiposity: An Examination of Periods of Heightened Susceptibility Between Gestation and Late ChildhoodJanice M Y Hu, Michael M Borghese, Mandy Fisher, et al.European Journal of Gastroenterology & Hepatology|June 18, 2010
Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogenDouglas G Ward, Wenbin Wei, John Buckels, et al.Proteome Science|June 19, 2008
Proteomic profiling of urine for the detection of colon cancerDouglas G Ward, Stephen Nyangoma, Howard Joy, et al.International Journal of Hygiene and Environmental Health|January 14, 2021
Urinary phthalates and body mass index in preschool children: The MIREC Child Development Plus studyJillian Ashley-Martin, Linda Dodds, Tye E Arbuckle, et al.Pulmonary Circulation|June 23, 2025
Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase-5 Inhibitors (PDE5i)Nicholas A Kolaitis, Martha Kingman, Melisa Wilson, et al.Pageof 15